• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Amandeep Kaur, BSc., MSc. – Research Associate 3, Medical Text Analysis and Synthetic Biology

Amandeep Kaur, BSc., MSc. – Research Associate 3, Medical Text Analysis and Synthetic Biology

https://pharmaceuticalintelligence.com/contributors-biographies/associates/amandeep-kaur-bsc-msc-9exp-5-2021-research-associate-2-medical-text-analysis-and-it-infrastructure-python-coder/

1. Publications on Pharmaceuticalintelligence.com

DateArticle NameURL  
7 August 2021Novartis uses a ‘dimmer switch’ medication to fine-tune gene therapy candidateshttps://pharmaceuticalintelligence.com/2021/08/07/novartis-uses-a-dimmer-switch-medication-to-fine-tune-gene-therapy-candidates/
7 June 2021 Emergence of a new SARS-CoV-2 variant from GR clade with a novel S glycoprotein mutation V1230L in West Bengal, India https://pharmaceuticalintelligence.com/2021/06/07/emergence-of-a-new-sars-cov-2-variant-from-gr-clade-with-a-novel-s-glycoprotein-mutation-v1230l-in-west-bengal-india/
29 May 2021Developing Machine Learning Models for Prediction of Onset of Type-2 Diabeteshttps://pharmaceuticalintelligence.com/2021/05/29/developing-machine-learning-models-for-prediction-of-onset-of-type-2-diabetes/
25 May 2021C.D.C. Reviewing Cases of Heart Problem in Youngsters After Getting Vaccinatedhttps://pharmaceuticalintelligence.com/2021/05/25/c-d-c-reviewing-cases-of-heart-problem-in-youngsters-after-getting-vaccinated/
4 May 2021Thriving Vaccines and Research: Weizmann Institute Coronavirus Research Developmenthttps://pharmaceuticalintelligence.com/2021/05/04/thriving-vaccines-and-research-weizmann-coronavirus-research-development/
19 April 2021Identification of Novel genes in human that fight COVID-19 infectionhttps://pharmaceuticalintelligence.com/2021/04/19/identification-of-novel-genes-in-human-that-fight-covid-19-infection/
13 April 2021Fighting Chaos with Care, community trust, engagement must be cornerstones of pandemic responsehttps://pharmaceuticalintelligence.com/2021/04/13/fighting-chaos-with-care/
21 March 2021Two brothers with MEPAN Syndrome: A Rare Genetic Disorderhttps://pharmaceuticalintelligence.com/2021/03/21/two-brothers-with-mepan-syndrome-a-rare-genetic-disorder/
11 Jan 2021 Dysregulation of ncRNAs in association with Neurodegenerative Disorders https://pharmaceuticalintelligence.com/2021/01/11/dysregulation-of-ncrnas-in-association-with-neurodegenerative-disorders/

2. Progress on Text Analysis

6 June 2021

LPBI Phase 2: Proof of Concept – Genomics Volume 1- Chapter 2 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Amandeep/Genomics%2C%20Vol1/Chapter%202

WORD CLOUDs Uploaded in Articles of Chapter 2

Article 2.1- https://pharmaceuticalintelligence.com/2013/02/11/2013-genomics-the-era-beyond-the-sequencing-human-genome-francis-collins-craig-venter-eric-lander-et-al/

Article 2.2- https://pharmaceuticalintelligence.com/2013/02/15/dna-structure-and-oligonucleotides/

Article 2.3- https://pharmaceuticalintelligence.com/2013/02/03/genome-wide-detection-of-single-nucleotide-and-copy-number-variation-of-a-single-human-cell/

Article 2.4- https://pharmaceuticalintelligence.com/2013/02/14/genomics-and-evolution/

Article 2.5- https://pharmaceuticalintelligence.com/2013/03/16/protein-folding-simulation-stanfords-framework-for-testing-and-predicting-evolutionary-outcomes-in-living-organisms/

Article 2.6- https://pharmaceuticalintelligence.com/2013/05/15/the-binding-of-oligonucleotides-in-dna-and-3-d-lattice-structures/

Article 2.7- https://pharmaceuticalintelligence.com/2013/05/15/finding-the-genetic-links-in-common-disease-caveats-of-whole-genome-sequencing-studies/

23 May 2021

LPBI Phase 2: Proof of Concept – Genomics Volume 1- Chapter 1 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Amandeep/Genomics%2C%20Vol1/Chapter%201

WORD CLOUDs Uploaded in Articles of Chapter 1

Article 1.1- https://pharmaceuticalintelligence.com/2013/02/08/the-initiation-and-growth-of-molecular-biology-and-genomics/

Article 1.2- https://pharmaceuticalintelligence.com/2013/02/12/cracking-the-code-of-human-life-milestones-along-the-way/

Article 1.3- https://pharmaceuticalintelligence.com/2012/08/27/dna-the-next-generation-storage-media-for-digital-information/

Article 1.4- https://pharmaceuticalintelligence.com/2013/02/14/cracking-the-code-of-human-life-recent-advances-in-genomic-analysis-and-disease/

Article 1.5- https://pharmaceuticalintelligence.com/2012/10/22/advances-in-separations-technology-for-the-omics-and-clarification-of-therapeutic-targets/

Article 1.6- https://pharmaceuticalintelligence.com/2012/08/22/genomic-analysis-fluidigm-technology-in-the-life-science-and-agricultural-biotechnology/

17 May 2021

LPBI Phase 2: Proof of Concept – Genomics Volume 1 – Chapter 21 Completion

Dropbox- Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Amandeep/Genomics%2C%20Vol1/Chapter%2021

WORD CLOUDs Uploaded in Articles of Chapter 21:

Article 21.1 Introducing CRISPR/Cas9 Gene Editing Technology – Works by Jennifer A. Doudna

Article 21.1.2- https://pharmaceuticalintelligence.com/2014/03/25/evaluate-your-cas9-gene-editing-vectors-crisprcas-mediated-genome-engineering-is-your-crispr-grna-optimized-for-your-cell-lines/
Article 21.1.3- https://pharmaceuticalintelligence.com/2014/06/13/215-245-6132014-jennifer-doudna-the-biology-of-crisprs-from-genome-defense-to-genetic-engineering/
Article 21.1.4- https://pharmaceuticalintelligence.com/2014/06/16/prediction-of-the-winner-rna-technology-the-frontier-of-science-on-rna-biology-cancer-and-therapeutics-the-start-up-landscape-in-boston/

Article 21.2 CRISPR in Other Labs
Article 21.2.1- https://pharmaceuticalintelligence.com/2014/04/21/crispr-mit-genome-surgery/
Article 21.2.3- https://pharmaceuticalintelligence.com/2014/10/29/new-frontiers-in-gene-editing-transitioning-from-the-lab-to-the-clinic-february-19-20-2015-the-intercontinental-san-francisco-san-francisco-ca/
Article 21.2.4- https://pharmaceuticalintelligence.com/2014/03/27/gene-therapy-and-the-genetic-study-of-disease-berkeley-and-ucsf-new-dna-editing-technology-spawns-bold-uc-initiative-as-crispr-goes-global/

Article 21.3 Patents Awarded and Pending for CRISPR
Article 21.3.1-  https://pharmaceuticalintelligence.com/2014/12/05/litigation-on-the-way-broad-institute-gets-patent-on-revolutionary-gene-editing-method/
Article 21.3.2- https://pharmaceuticalintelligence.com/2014/12/05/the-patents-for-crispr-the-dna-editing-technology-as-the-biggest-biotech-discovery-of-the-century/

Article 21.4 CRISPR/Cas9 Applications
Article 21.4.2- https://pharmaceuticalintelligence.com/2014/11/04/crispr-applications-for-autoimmune-diseases-ucsf/
Article 21.4.4- https://pharmaceuticalintelligence.com/2015/08/30/delineating-a-role-for-crispr-cas9-in-pharmaceutical-targeting/
Article 21.4.5- https://pharmaceuticalintelligence.com/2015/09/01/where-is-the-most-promising-avenue-to-success-in-pharmaceuticals-with-crispr-cas9/
Article 21.4.6- https://pharmaceuticalintelligence.com/2015/08/30/level-of-comfort-with-making-changes-to-the-dna-of-an-organism/

Article 21.4.7- https://pharmaceuticalintelligence.com/2015/09/01/who-will-be-the-the-first-to-ipo-novartis-bought-in-to-intellia-uc-berkeley-as-well-as-caribou-vs-editas-mit/

Article 21.4.8- https://pharmaceuticalintelligence.com/2015/09/02/crisprcas9-finds-its-way-as-an-important-tool-for-drug-discovery-development/

28 March 2021

Streamlined the WORKFLOW for MEDICAL TEXT ANALYSIS based on INSTRUCTIONS given by MADISON and MODIFIED by Aviva

The workflow is as Follows:

1.  One MS Word file for All Articles in a chapter – Chapter’s subject CONTEXT as UNIT CASE for Text Analysis by NLP

2.  One Text file for All Articles in a chapter – to be used for Wolfram NLP

3.  One MS Word File Containing All the Biological Images with Article Name, Author, URL of All Articles in a chapter – to be use for uploading images to the Gallery of the NEW WEBSITE for 2.0 LPBI [under construction]

4.  One MS Word file per Article  – to be INDEXED for Blockchain Transactions Network

5.  One Text file per Article – to be used for 2, above

6.  One WordCloud per Article – Test Analysis visual #1

7.  One Bar Diagram from Above option 1 (means All Articles) – Test Analysis visual #2

7.1  One Bar Diagram produced from 2, above – Text Analysis visual # 2.1 – Word frequency for Subject Context of the Chapter 

8.  One Wolfram Hyper-graph from Above option 1 (means All Articles) – Test Analysis visual #3

9.  One Tree Diagram from Above option 1 (means All Articles) – Test Analysis visual #4

10.  One PowerPoint Presentation PER CHAPTER containing WordClouds, bar diagrams, hyper-graphs, tree diagrams of i.e., Genomic Vol 1 (means All chapters) – Test Analysis visual #5

11.  Domain Knowledge Expert Interpretations in English Text for 8, above – Test Analysis Interpretation of Hyper-graph in English Text File #6 [Place holder for Dr. Williams]

12.  Domain Knowledge Expert Interpretations in English Text for 9, above – Test Analysis Interpretation of Tree Diagram in English Text File #7 [Place holder for Dr. Williams]

13.  Translation of 11, above [Interpretation of Hyper-graph] into three languages each – Test Analysis Translation Texts

#8, #9, #10 [three place holders]

14.  Translation of 12, above [Interpretation of Tree diagram] into three languages each – Test Analysis Translation Texts #11, #12, #13 [three place holders]

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 1,979 other subscribers

  • Recent Posts

    • Omecamtiv mecarbil – A study examined efficacy and tolerability in Heart Failure patients with SBP ≤100 mmHg enrolled in GALACTIC-HF May 23, 2022
    • Sperm epigenetic clock and pregnancy outcomes May 14, 2022
    • Lessons on the Frontier of Gene & Cell Therapy – The Disruptive Dozen 12 #GCT Breakthroughs that are revolutionizing Healthcare May 9, 2022
    • Relevance of Twitter.com forthcoming Payment System for Scientific Content Promotion and Monetization May 9, 2022
    • Tweets at #WMIF2022 by @pharma_BI & @AVIVA1950 and all Retweets of these Tweets – 2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON May 7, 2022
    • Data Science: Step by Step – A Resource for LPBI Group’s One-Year Internship in IT, IS, DS May 7, 2022
    • 2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON • IN-PERSON May 1, 2022
    • We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022 April 25, 2022
    • The durability of T cells versus the triggered of high levels of antibodies: Rationale for the development of T cells focused vaccines   April 22, 2022
    • The Framingham Study: Across 6 Decades, Cardiovascular Disease Among Middle-Aged Adults – mean life expectancy increased and the RLR of ASCVD decreased. Effective primary prevention efforts and better screening increased. April 22, 2022
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 Rosalind Codrington, PhD
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: